Cargando…
“Cerberus” T Cells: A Glucocorticoid-Resistant, Multi-Pathogen Specific T Cell Product to Fight Infections in Severely Immunocompromised Patients
Adoptive immunotherapy (AI) with pathogen-specific T cells is a promising alternative to pharmacotherapy for the treatment of opportunistic infections after allogeneic hematopoietic cell transplantation or solid organ transplantation. However, clinical implementation of AI is limited to patients not...
Autores principales: | Koukoulias, Kiriakos, Papayanni, Penelope-Georgia, Georgakopoulou, Aphrodite, Alvanou, Maria, Laidou, Stamatia, Kouimtzidis, Anastasios, Pantazi, Chrysoula, Gkoliou, Glykeria, Vyzantiadis, Timoleon-Achilleas, Spyridonidis, Alexandros, Makris, Antonios, Chatzidimitriou, Anastasia, Psatha, Nikoletta, Anagnostopoulos, Achilles, Yannaki, Evangelia, Papadopoulou, Anastasia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848034/ https://www.ncbi.nlm.nih.gov/pubmed/33537032 http://dx.doi.org/10.3389/fimmu.2020.608701 |
Ejemplares similares
-
Empowering the Potential of CAR-T Cell Immunotherapies by Epigenetic Reprogramming
por: Alvanou, Maria, et al.
Publicado: (2023) -
Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity
por: Papadopoulou, Anastasia, et al.
Publicado: (2021) -
Vaccinated and Convalescent Donor–Derived Severe Acute Respiratory Syndrome Coronavirus 2–Specific T Cells as Adoptive Immunotherapy for High-Risk Coronavirus Disease 2019 Patients
por: Papayanni, Penelope-Georgia, et al.
Publicado: (2021) -
Distinctive Signaling Profiles With Distinct Biological and Clinical Implications in Aggressive CLL Subsets With Stereotyped B-Cell Receptor Immunoglobulin
por: Gerousi, Marina, et al.
Publicado: (2021) -
The TΑp63/BCL2 axis represents a novel mechanism of clinical aggressiveness in chronic lymphocytic leukemia
por: Laidou, Stamatia, et al.
Publicado: (2022)